Aktinos Pharma Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 4.03 Cr
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 112.97 Cr
- Satisfied Charges ₹ 42.27 Cr
- Revenue Growth -9.54%
- Profit Growth -2131.81%
- Ebitda -97.34%
- Net Worth -27.39%
- Total Assets 9.07%
About Aktinos Pharma
Aktinos Pharma Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 September 2007 and has a history of 17 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 4.03 Cr.
The company currently has active open charges totaling ₹112.97 Cr. The company has closed loans amounting to ₹42.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Murali Madala, Srilakshmi Madala, Vineeth Madala, and One other member serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TG2007PTC055510
-
Company No.
055510
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Sep 2007
-
Date of AGM
30 Dec 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Aktinos Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murali Madala
|
Managing Director | 13-Sep-2007 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Srilakshmi Madala
|
Whole-Time Director | 13-Sep-2007 | Current |
|
Vineeth Madala
|
Director | 01-Aug-2022 | Current |
Ravishanker Kovi
|
Director | 24-Jul-2017 | Current |
Financial Performance of Aktinos Pharma.
Aktinos Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.54% decrease. The company also saw a substantial fall in profitability, with a 2131.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aktinos Pharma?
In 2023, Aktinos Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Apicore Pharmaceuticals Private LimitedMurali Madala and Ravishanker Kovi are mutual person
-
4C Drug Safety Services LlpMurali Madala is a mutual person
-
Sr Generics Private Limited
Murali Madala is a mutual person
-
Agribolt Sciences Private Limited
Vineeth Madala is a mutual person
-
Trominosoft Llp
Ravishanker Kovi is a mutual person
Charges (Loans)
₹112.97 Cr
₹42.27 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 59.19 Cr
- Axis Bank Limited : 24.60 Cr
- Citi Bank N.A. : 17.00 Cr
- Others : 12.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2024 | Citi Bank N.A. | ₹17.00 Cr | Open |
| 28 Feb 2023 | Others | ₹1.71 Cr | Open |
| 28 Feb 2023 | Others | ₹8.87 M | Open |
| 12 Jul 2022 | Others | ₹1.00 Cr | Open |
| 28 Feb 2022 | Others | ₹1.38 Cr | Open |
How Many Employees Work at Aktinos Pharma?
Aktinos Pharma has a workforce of 411 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aktinos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aktinos Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
